STW 5 in 1515 patients with functional gastrointestinal diseases

被引:0
|
作者
Moeller, J. [1 ]
Raskopf, E. [2 ,3 ]
Greinert, O. [3 ]
Zadoyan, G. [3 ]
Schleicher, S. [3 ]
Shah-Hosseini, K. [3 ]
Wegener, T. [4 ,5 ]
Kelber, O. [1 ,4 ]
Singh, J. [2 ,3 ]
Kraft, K. [4 ,6 ]
Nieber, K. [4 ,7 ]
Moesges, R. [2 ,3 ]
机构
[1] Steigerwald Arzneimittelwerk GmbH, Phytomed Supply & Dev Ctr, Bayer Consumer Hlth Innovat & Dev, Havelstr 5, D-64295 Darmstadt, Germany
[2] ClinNovis GmbH, Genter Str 7, D-50672 Cologne, Germany
[3] Univ Hosp Cologne, Inst Med Stat & Computat Biol, Kerpener Str 62, D-50937 Cologne, Germany
[4] Kooperat Phytopharmaka GbR, Plittersdorfer Str 218, D-53173 Bonn, Germany
[5] Consulting HMP, Bruckstr 11, D-69469 Weinheim, Germany
[6] Univ Med Rostock, Lehrstuhl Nat Heilkunde, Ernst Heydemann Str 6, D-18057 Rostock, Germany
[7] Univ Leipzig, Inst Pharm, Bruderstr 34, D-04103 Leipzig, Germany
关键词
D O I
10.1055/s-0039-3400131
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
P-422
引用
收藏
页码:1561 / 1562
页数:2
相关论文
共 50 条
  • [1] New options for the treatment of functional gastrointestinal diseases with the phytomedicine STW 5
    Krueger, D.
    Gruber, L.
    Angay, O.
    Zeller, F.
    Kelber, O.
    Vinson, B.
    Weiser, D.
    Schemann, M.
    PLANTA MEDICA, 2008, 74 (09) : 911 - 911
  • [2] STW 5 in patients with irritable bowel syndrome and other functional gastrointestinal diseases: Results of a surveillance study
    Vinson, B.
    Skeib, S.
    Kelber, O.
    Raskopf, E.
    Nieber, K.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [3] Herbal medicinal products in the public pharmacy: a surveillance study with STW 5 in patients with functional gastrointestinal diseases
    Vinson, B.
    Skeib, S.
    Kolb, C.
    Kelber, O.
    Nieber, K.
    PLANTA MEDICA, 2019, 85 (18) : 1560 - 1560
  • [4] Pharmacological profile of STW 5 opens new options for the treatment of functional gastrointestinal diseases
    Krueger, D.
    Gruber, L.
    Angay, O.
    Zeller, F.
    Kelber, O.
    Schemann, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 60 - 60
  • [5] STW 5 (Iberogast) Therapy in Gastrointestinal Functional Disorders
    Malfertheiner, Peter
    DIGESTIVE DISEASES, 2017, 35 : 25 - 29
  • [6] Therapy of functional gastrointestinal diseases in the pediatric population: Review of clinical data for the phytomedicine STW 5
    Gundermann, K-J
    Vinson, B. R.
    Kelber, O.
    Weiser, D.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 : 69 - 69
  • [7] Functional gastrointestinal diseases in children: Pharmacoepidemiological data on STW 5 from the PhytoVIS data base
    Schmidt, C.
    Moeller, J.
    Kelber, O.
    Nieber, K.
    PLANTA MEDICA, 2021, 87 (15) : 1282 - 1283
  • [8] Pharmacoepidemiology of functional gastrointestinal diseases in children under therapy with a herbal medicinal product, STW 5
    Moeller, Johanna
    Kelber, Olaf
    Nieber, Karen
    INTERNIST, 2021, 62 (SUPPL 2): : 159 - 159
  • [9] Functional gastrointestinal diseases: Epidemiological data from 1515 patients under an herbal therapy
    Moeller, J.
    Raskopf, E.
    Greinert, O.
    Zadoyan, G.
    Schleicher, S.
    Sha-Hosseini, K.
    Kelber, O.
    Singh, J.
    Moesges, R.
    Nieber, K.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [10] Herbal Preparation STW 5 for Functional Gastrointestinal Disorders: Clinical Experience in Everyday Practice
    Lapina, Tatiana L.
    Trukhmanov, Alexander S.
    DIGESTIVE DISEASES, 2017, 35 : 30 - 35